MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, IDXG has $33,409K in assets. $10,327K in debts. $2,647K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
251.46%
Quick Ratio
251.46%
Cash Ratio
66.81%
Debt to Asset Ratio
30.91%
Unit: Thousand (K) dollars
Assets Breakdown
    • Deferred tax asset
    • Accounts receivable
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Other long-term liabilities
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
2,647 2,505 1,423 502
Accounts receivable
5,925 5,649 5,966 7,231
Other current assets
1,391 1,746 1,741 1,771
Total current assets
9,963 9,900 9,130 9,504
Property and equipment, net
1,315 1,423 1,541 1,366
Operating lease right of use assets
1,110 1,217 1,320 1,420
Deferred tax asset
20,977 21,254 --
Other long-term assets
44 44 45 45
Total assets
33,409 33,838 12,036 12,335
Accounts payable
805 983 1,411 1,250
Accrued salary and bonus
714 1,886 1,447 2,045
Other accrued expenses
1,783 1,574 1,450 1,422
Note payable at fair value
--977 1,772
Current liabilities of discontinued operations
660 660 660 660
Total current liabilities
3,962 5,103 5,945 7,149
Operating lease liabilities, net of current portion
635 752 864 974
Other long-term liabilities
5,730 5,620 5,525 5,425
Redeemable preferred stock, .01 par value 5,000,000 shares authorized, 47,000 shares series c issued and outstanding
---0
Total liabilities
10,327 11,475 12,334 13,548
Common stock, .01 par value 100,000,000 shares authorized 27,844,994 and 4,569,333 shares issued, respectively 27,700,904 and 4,428,539 shares outstanding, respectively
640 407 407 407
Additional paid-in capital
234,604 234,833 234,829 234,822
Accumulated deficit
-210,084 -210,805 -233,462 -234,373
Treasury stock, at cost (144,090 and 140,794 shares, respectively)
2,078 2,072 2,072 2,069
Total stockholders equity
23,082 22,363 -298 -1,213
Total liabilities and stockholders equity
33,409 33,838 12,036 12,335
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Accounts receivable$5,925K Cash and cashequivalents$2,647K Other current assets$1,391K Deferred tax asset$20,977K Total current assets$9,963K Property and equipment,net$1,315K Operating lease right ofuse assets$1,110K Other long-termassets$44K Total assets$33,409K Total liabilities andstockholders equity$33,409K Total stockholdersequity$23,082K Total liabilities$10,327K Accumulated deficit-$210,084K Treasury stock, at cost(144,090 and 140,794...$2,078K Additional paid-in capital$234,604K Other long-termliabilities$5,730K Total currentliabilities$3,962K Operating leaseliabilities, net of current...$635K Common stock, .01 parvalue 100,000,000...$640K Other accruedexpenses$1,783K Accounts payable$805K Accrued salary and bonus$714K Current liabilities ofdiscontinued operations$660K

INTERPACE BIOSCIENCES, INC. (IDXG)

INTERPACE BIOSCIENCES, INC. (IDXG)